Autologous Transplantation as Consolidation for High Risk Aggressive T-Cell Non-Hodgkin's Lymphoma: A SWOG 9704 Intergroup Trial Subgroup Analysis

Phase II data suggest a benefit to autotransplantation for aggressive T-NHL in first remission; randomized trials have yet to validate this. We performed a retrospective analysis of aggressive T-NHL patients in the intergroup randomized consolidative autotransplant trial (SWOG 9704). Of the 370 enro...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Leuk Lymphoma
Main Authors: Al-Mansour, Zeina, Li, Hongli, Cook, James R., Constine, Louis S., Couban, Stephen, Stewart, Douglas A., Shea, Thomas C., Porcu, Pierluigi, Winter, Jane N., Kahl, Brad S., Smith, Sonali M., Marcellus, Deborah C., Barton, Kevin P., Mills, Glenn M., LeBlanc, Michael, Rimsza, Lisa M., Forman, Stephen J., Leonard, John P., Fisher, Richard I., Friedberg, Jonathan W., Stiff, Patrick J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6620162/
https://ncbi.nlm.nih.gov/pubmed/30628511
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10428194.2018.1563691
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados